Schedule 13G ownership disclosure

HELIUS MEDICAL TECHNOLOGIES, INC.

Common Stock, $0.001 par value per share · CUSIP: 42328V884

Event date: 2025-08-14

Filing-level shares
640.00
Percent of class
1.01%
  • L1 Capital Global Opportunities Master Fund, Ltd.

    Shares: 640.00 · Class: 1.01%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001079973-25-001318
Form type
SCHEDULE 13G/A
Filer
Solana Co
CIK
CIK 1610853
Filed
Aug 14, 2025
Reporting period
Aug 14, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub